SLB

Schlumberger
D

SLB

Arincen68/100B

Schlumberger return on equity (ROE)

Schlumberger's return on equity is 12.21%: net income of 3.18B USD over the last twelve months on shareholders' equity of 26.05B USD.

Today
12.21%
Average, 5 years
17.99%
Low, 5 years
12.17%
High, 5 years
21.92%

ROE (return on equity) = net income (last 12 months) ÷ shareholders' equity = 3.18B ÷ 26.05B = 12.21%

ROE (return on equity)
Net income
Shareholders' equity

Each quarter's net income over its last four quarters, over the shareholders' equity at the quarter end.

Why is Schlumberger's return on equity so high?

Net margin
9.4%
profit on each dollar of sales
Asset turnover
0.65×
sales on each dollar of assets
Equity multiplier
2.10×
assets on each dollar of equity
Return on equity
12.8%
FY2025
  • FY20259.4% × 0.65 × 2.10 = 12.8%
  • FY202412.3% × 0.74 × 2.32 = 21.1%
  • FY202312.7% × 0.69 × 2.38 = 20.8%
  • FY202212.2% × 0.65 × 2.44 = 19.5%
  • FY20218.2% × 0.55 × 2.77 = 12.5%

The DuPont breakdown, on each year-end's assets and equity, as the return on equity elsewhere on this page. A high equity multiplier means a small equity base: debt, or buybacks that return the equity to shareholders, lift the return on what is left.

ROE (return on equity) by year and by quarter

Fiscal yearPeriod endingROE (return on equity)Net incomeShareholders' equity
Today12.21%3.18B26.05B
FY202531 Dec 202512.92%3.37B26.11B
FY202431 Dec 202421.67%4.58B21.13B
FY202331 Dec 202321.17%4.28B20.19B
FY202231 Dec 202219.75%3.49B17.69B
FY202131 Dec 202112.85%1.93B15.00B
FY202031 Dec 2020-86.87%-10.49B12.07B
FY201931 Dec 2019-42.54%-10.11B23.76B
FY201831 Dec 20186.02%2.18B36.16B
FY201731 Dec 2017-4.11%-1.51B36.84B
FY201631 Dec 2016-3.96%-1.63B41.08B
FY201531 Dec 20155.99%2.14B35.63B
FY201431 Dec 201415.09%5.71B37.85B
FY201331 Dec 201317.34%6.84B39.47B
FY201231 Dec 201215.73%5.47B34.75B
FY201131 Dec 201116.03%5.01B31.26B
FY201031 Dec 201013.66%4.27B31.23B
FY200931 Dec 200916.43%3.14B19.12B
FY200831 Dec 200832.01%5.40B16.86B
FY200731 Dec 200734.80%5.18B14.88B
FY200631 Dec 200635.60%3.71B10.42B
FY200531 Dec 200528.97%2.20B7.59B
FY200431 Dec 200416.58%1.01B6.12B
FY200331 Dec 20038.03%472.56M5.88B
FY200231 Dec 2002-43.12%-2.42B5.61B
FY200131 Dec 20016.23%522.22M8.38B
FY200031 Dec 20008.86%734.60M8.30B
FY199931 Dec 19994.75%366.70M7.72B
FY199831 Dec 199812.49%1.01B8.12B
FY199731 Dec 199717.55%1.30B7.38B
FY199631 Dec 199615.13%851.50M5.63B
FY199531 Dec 199513.08%649.20M4.96B
FY199431 Dec 199411.70%536.10M4.58B
FY199331 Dec 199313.23%582.80M4.41B
FY199231 Dec 199215.64%661.60M4.23B
FY199131 Dec 199121.17%815.70M3.85B
FY199031 Dec 199017.52%570.30M3.25B
FY198931 Dec 198914.49%420.00M2.90B
FY198831 Dec 198816.48%453.90M2.76B
FY198731 Dec 19877.37%282.60M3.84B
FY198631 Dec 1986-48.93%-2.02B4.12B
FY198531 Dec 19855.10%351.00M6.88B

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.

See also:P/E ratio,Market cap,P/S ratio,Dividend yield,Debt to equity,Current ratio,All ratios

Common questions about Schlumberger's ROE

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.